Altamira Therapeutics
CYTO
#8281
Rank
$3.62 M
Marketcap
🇧🇲 Bermuda
Country
$1.62
Share price
0.00%
Change (1 day)
97.56%
Change (1 year)
Categories
EPS for Altamira Therapeutics (CYTO)
EPS in 2019 (TTM): -$307.85
According to Altamira Therapeutics's latest financial reports the company's current EPS (TTM) is -$307.85. In 2018 the company made an earnings per share (EPS) of -$433.56 an increase over its 2017 EPS that were of -$2,343.
EPS history for Altamira Therapeutics from 2013 to 2019
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2019 (TTM) | -$307.85 | -28.99% |
| 2018 | -$433.56 | -81.5% |
| 2017 | -$2,343 | -36.52% |
| 2016 | -$3,691 | -5.17% |
| 2015 | -$3,892 | 7.77% |
| 2014 | -$3,612 | 0.33% |
| 2013 | -$3,600 |